Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Taylor Cousar, Jennifer L ^a   Zariwala, Maimoona A ^b   Burch, Lauranell H ^c   Pace, Rhonda G ^b   Drumm, Mitchell L ^e   Calloway, Hollin ^b   Fan, Haiying ^b   Weston, Brent W ^b   Wright, Fred A ^d   Knowles, Michael R ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d IL   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FUCOSYLTRANSFERASE; PROTEIN FUT2; PROTEIN FUT3; UNCLASSIFIED DRUG; BLOOD GROUP ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ASTHMA; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA EXTRACTION; GENDER; GENE MUTATION; GENE SEQUENCE; GLYCOSYLATION; GRAM NEGATIVE INFECTION; HOMOZYGOSITY; HUMAN; LUNG DISEASE; LUNG INFECTION; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; MECONIUM ILEUS; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LUNG; MALE; METABOLISM; MICROBIOLOGY; MUCUS; PATHOLOGY; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; CYSTIC FIBROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MALE; MUCUS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 59249089989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004270     Document Type: Article

References (46)

1. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 19: 575-606.
2. Riordan JR RJ, Kerem BS, Alon N, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1059-1065.
3. Cystic Fibrosis Mutation Data Base.
4. Cutting GR (2005) Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 6: 237-260.
5. Boyle MP (2007) Strategies for identifying modifier genes in cystic fibrosis. Proc Am Thorac Soc 4: 52-57.
6. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577.
7. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168: 918-951.
8. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, et al. (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Jama 293: 581-588.
9. Wat D, Gelder C, Hibbitts S, Cafferty F, Bowler I, et al. (2008) The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 7: 320-328.
10. Wang EE, Prober CG, Manson B, Corey M, Levison H (1984) Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 311: 1653-1658.
11. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, et al. (2001) ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83: 565-573.
12. Yip SP (2002) Sequence variation at the human ABO locus. Ann Hum Genet 66: 1-27.
13. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, et al. (2003) Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188: 19-31.
14. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoen-Clouet N (2005) Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis 192: 1071-1077.
15. Saadi AT, Weir DM, Poxton IR, Stewart J, Essery SD, et al. (1994) Isolation of an adhesin from Staphylococcus aureus that binds Lewis a blood group antigen and its relevance to sudden infant death syndrome. FEMS Immunol Med Microbiol 8: 315-320.
16. Wu AM, Wu JH, Singh T, Liu JH, Tsai MS, et al. (2006) Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. Biochimie 88: 1479-1492.
17. Cohen BH, Bias WB, Chase GA, Diamond EL, Graves CG, et al. (1980) Is ABH nonsecretor status a risk factor for obstructive lung disease? Am J Epidemiol 111: 285-291.
18. Kauffmann F, Frette C, Pham QT, Nafissi S, Bertrand JP, et al. (1996) Associations of blood group-related antigens to FEV1, wheezing, and asthma. Am J Respir Crit Care Med 153: 76-82.
19. Ronchetti F, Villa MP, Ronchetti R, Bonci E, Latini L, et al. (2001) ABO/ Secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J 17: 1236-1238.
20. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, et al. (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443-1453.
21. Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR (2006) Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 174: 780-786.
22. Svensson L, Petersson A, Henry SM (2000) Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A, and other mutations from a single PCR. Transfusion 40: 856-860.
23. Salomaa V, Pankow J, Heiss G, Cakir B, Eckfeldt JH, et al. (2000) Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disease in the NHLBI family heart study. J Intern Med 247: 689-698.
24. Cameron HS, Szczepaniak D, Weston BW (1995) Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J Biol Chem 270: 20112-20122.
25. Pang H, Liu Y, Koda Y, Soejima M, Jia J, et al. (1998) Five novel missense mutations of the Lewis gene (FUT3) in African (Xhosa) and Caucasian populations in South Africa. Hum Genet 102: 675-680.
26. Harmening D (1999) Modern Blood Banking and Transfusion Practice; Harmening D, ed. Philadelphia: F.A. Davis Company.
27. dbSNP.
28. Orntoft TF, Vestergaard EM, Holmes E, Jakobsen JS, Grunnet N, et al. (1996) Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J Biol Chem 271: 32260-32268.
29. Rhim AD, Stoykova L, Glick MC, Scanlin TF (2001) Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell. Glycoconj J 18: 649-659.
30. Pittman J CH, Yeatts J, Drumm M, Leigh M, Davis S, Van Rie A, Emomnd M, Knowles M (2008) Age of Pseudomonas Aeruginosa Infection and Severity of Adult Lung Disease in Cystic Fibrosis. Pediatric Pulmonology 43: A332.
31. Rowntree RK, Harris A (2003) The phenotypic consequences of CFTR mutations. Ann Hum Genet 67: 471-485.
32. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, et al. (1990) The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N Engl J Med 323: 1517-1522.
33. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, et al. (2007) Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 175: 1036-1043.
34. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082.
35. Haponik EF, Stokes D, Rosenstein BJ, Hughes WT (1985) ABH secretor status in cystic fibrosis-a negative report. Eur J Respir Dis 67: 381-384.
36. Shori DK, Genter T, Hansen J, Koch C, Wyatt H, et al. (2001) Altered sialy-land fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7. Pflugers Arch 443 Suppl 1: S55-61.
37. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA (2000) Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137: 374-380.
38. Imundo L, Barasch J, Prince A, Al-Awqati Q (1995) Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci U S A 92: 3019-3023.
39. Devaraj N, Sheykhnazari M, Warren WS, Bhavanandan VP (1994) Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins. Glycobiology 4: 307-316.
40. Carnoy C, Ramphal R, Scharfman A, Lo-Guidice JM, Houdret N, et al. (1993) Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 9: 323-334.
41. Komiyama K, Habbick BF, Tumber SK (1987) Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect Immun 55: 2364-2369.
42. Clamp JR, Gough M (1979) Study of the oligosaccharide units from mucus glycoproteins of meconium from normal infants and from cases of cystic fibrosis with meconium ileus. Clin Sci (Lond) 57: 445-451.
43. Thiru S, Devereux G, King A (1990) Abnormal fucosylation of ileal mucus in cystic fibrosis: I. A histochemical study using peroxidase labelled lectins. J Clin Pathol 43: 1014-1018.
44. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, et al. (2002) Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase. Biochem J 367: 609-616.
45. Elmgren A, Grahn A, Gronowitz E, Aberg L, Heikenheimo M, et al. (2002) Lewis and secretor genotypes modify the phenotype in patients with cystic fibrosis. Pediatric Pulmonology 34: 226.
46. Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, et al. (2008) Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 17: 2228-2237.